Literature DB >> 16458093

Evaluation of the clinical age-related maculopathy staging system.

Johanna M Seddon1, Sanjay Sharma, Ron A Adelman.   

Abstract

OBJECTIVE: To evaluate a clinical classification system, the Clinical Age-Related Maculopathy Staging (CARMS) system, for age-related maculopathy (ARM) using a simple grading scale designed for clinical practice and clinical research protocols. PARTICIPANTS: Two hundred forty-six male and female participants with various stages of ARM who were enrolled during the first 4 years of a longitudinal study were selected for the evaluation of the CARMS system.
DESIGN: Cross-sectional comparison study.
METHODS: The CARMS system divides patients into 5 mutually exclusive categories based on slit-lamp assessment of drusen, retinal pigment epithelial irregularities, geographic atrophy, retinal pigment epithelial detachment, and choroidal neovascularization. Fundus photographs and clinical data of the subjects were used to evaluate this scale. Clinical grades assigned for 492 eyes of 246 patients with varying stages of ARM were compared with grades obtained from photographs evaluated by a reading center. To compare grades obtained from an inexperienced grader with those of an experienced grader, observations based on photographs from 50 randomly selected patients were reviewed. To quantify intraobserver agreement for photographic grades, observations from one observer were compared with those made at a later date by the same observer. MAIN OUTCOME MEASURES: Reliability and validity of the CARMS system in grading various stages of ARM based on clinical examination and photography.
RESULTS: The degree of overall agreement between the clinically assigned grade and photographic assessment for 492 eyes was substantial (exact overall agreement, 75%; unweighted kappa, 0.63; weighted kappa, 0.78). For advanced age-related macular degeneration, the sensitivity was 0.83, and specificity was 0.97. When assessing photographic grades, the degree of agreement between an inexperienced and an experienced grader was very high (unweighted kappa, 0.79; weighted kappa, 0.86), and the degree of intraobserver agreement was excellent (unweighted kappa, 0.92; weighted kappa, 0.97).
CONCLUSIONS: The CARMS system, a 5-level clinical scale, is a valid and reliable staging system that can be used in both clinical practice and in clinical research protocols involving patients with all stages of ARM.

Entities:  

Mesh:

Year:  2006        PMID: 16458093     DOI: 10.1016/j.ophtha.2005.11.001

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  118 in total

1.  Automated discovery and quantification of image-based complex phenotypes: a twin study of drusen phenotypes in age-related macular degeneration.

Authors:  Gwenole Quellec; Stephen R Russell; Johanna M Seddon; Robyn Reynolds; Todd Scheetz; Vinit B Mahajan; Edwin M Stone; Michael D Abràmoff
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-11-25       Impact factor: 4.799

2.  Prospective assessment of genetic effects on progression to different stages of age-related macular degeneration using multistate Markov models.

Authors:  Yi Yu; Robyn Reynolds; Bernard Rosner; Mark J Daly; Johanna M Seddon
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-03-21       Impact factor: 4.799

3.  Risk models for progression to advanced age-related macular degeneration using demographic, environmental, genetic, and ocular factors.

Authors:  Johanna M Seddon; Robyn Reynolds; Yi Yu; Mark J Daly; Bernard Rosner
Journal:  Ophthalmology       Date:  2011-09-29       Impact factor: 12.079

4.  Adherence to a Mediterranean diet, genetic susceptibility, and progression to advanced macular degeneration: a prospective cohort study.

Authors:  Bénédicte M J Merle; Rachel E Silver; Bernard Rosner; Johanna M Seddon
Journal:  Am J Clin Nutr       Date:  2015-10-21       Impact factor: 7.045

Review 5.  Optical Coherence Tomography Monitoring Strategies for A-VEGF-Treated Age-Related Macular Degeneration: An Evidence-Based Analysis.

Authors:  G Pron
Journal:  Ont Health Technol Assess Ser       Date:  2014-08-01

6.  Association between retinal thickness measured by spectral-domain optical coherence tomography (OCT) and rod-mediated dark adaptation in non-exudative age-related maculopathy.

Authors:  Mark E Clark; Gerald McGwin; David Neely; Richard Feist; John O Mason; Martin Thomley; Milton F White; Bunyamin Ozaydin; Christopher A Girkin; Cynthia Owsley
Journal:  Br J Ophthalmol       Date:  2011-02-02       Impact factor: 4.638

7.  Variation near complement factor I is associated with risk of advanced AMD.

Authors:  Jesen A Fagerness; Julian B Maller; Benjamin M Neale; Robyn C Reynolds; Mark J Daly; Johanna M Seddon
Journal:  Eur J Hum Genet       Date:  2008-08-06       Impact factor: 4.246

8.  Ocular perfusion pressure and choroidal thickness in eyes with polypoidal choroidal vasculopathy, wet-age-related macular degeneration, and normals.

Authors:  P Rishi; E Rishi; G Mathur; V Raval
Journal:  Eye (Lond)       Date:  2013-06-14       Impact factor: 3.775

9.  Choriocapillaris dropout in early age-related macular degeneration.

Authors:  Gerard A Lutty; D Scott McLeod; Imran A Bhutto; Malia M Edwards; Johanna M Seddon
Journal:  Exp Eye Res       Date:  2020-01-24       Impact factor: 3.467

10.  The incidental findings of age-related macular degeneration during diabetic retinopathy screening.

Authors:  Rita Gangwani; Wico W Lai; Rita Sum; Sarah M McGhee; Catherine W S Chan; Anthony J Hedley; David Wong
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2013-11-27       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.